Abbvie (ABBV) PT Raised to $212 at Barclays
Get Alerts ABBV Hot Sheet
Price: $260.73 -0.38%
Rating Summary:
28 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 16 | New: 22
Rating Summary:
28 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 16 | New: 22
Join SI Premium – FREE
Barclays analyst Carter Gould raised the price target on Abbvie (NYSE: ABBV) to $212.00 (from $200.00) while maintaining a Overweight rating.
You May Also Be Interested In
- AbbVie's etentamig meets Phase 3 endpoints in multiple myeloma trial
- Strike Co Ltd (6196:JP) PT Raised to JPY555 at Macquarie
- JPMorgan Downgrades ZTO Express Cayman (2057:HK) (ZTO) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share